Landmark Bio is a biotechnology industry.
Landmark Bio has raised $18.3M in total funding. The most recent round was Grant. The last funding was announced in April 2026.
Landmark Bio's investors include Advanced Research Projects Agency for Health, National Institute for Innovation in Manufacturing Biopharmaceuticals.
Landmark Bio is headquartered in Boston, United States.
Landmark Bio is a biotechnology industry.
Landmark Bio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Landmark Bio — Funding & Investors." VCBacked, April 1, 2026, https://www.vcbacked.co/company/landmark-bio. Accessed August 14, 2026.
VCBacked. (2026). Landmark Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/landmark-bio
{{cite web |title=Landmark Bio — Funding & Investors |url=https://www.vcbacked.co/company/landmark-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated